U.S. markets closed

BrainsWay Ltd. (BWAY)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.8150+0.0650 (+3.71%)
At close: 03:59PM EDT
1.8300 +0.01 (+0.83%)
After hours: 06:54PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.7500
Bid1.6000 x 3000
Ask1.8300 x 1000
Day's Range1.7500 - 1.8450
52 Week Range1.6400 - 9.1800
Avg. Volume85,330
Market Cap30.022M
Beta (5Y Monthly)0.16
PE Ratio (TTM)N/A
EPS (TTM)-0.7800
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.05
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for BWAY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Brainsway Ltd.
    Analyst Report: Silk Road Medical IncBased in Sunnyvale, California, Silk Road Medical is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called Transcarotid Artery Revascularization (TCAR). TCAR combines the surgical principles of neuroprotection with minimally invasive endovascular techniques to treat carotid artery blockages that may cause strokes. The TCAR procedure involves threading a balloon catheter into the carotid artery from an incision near the groin to expand the narrowed artery. In parallel with the catheter procedure, another device is deployed to temporarily reverse blood flow to the brain in order to prevent any broken off clots from moving to the brain.
    Fair Value
    Economic Moat
    last yearArgus Research
View more
  • GlobeNewswire

    BrainsWay Post-Marketing Study Confirms Substantial Clinical Benefits of Deep TMS™ in Treating Depression and Anxious Depression

    Real-World Evidence Demonstrates the Highest Response and Remission Rates Observed to Date for Deep BURLINGTON, Mass. and JERUSALEM, March 28, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the publication of an expansive post-marketing data analysis demonstrating high response and remission rates for depression and anxious depression pat

  • GlobeNewswire

    BrainsWay Reports Fourth Quarter and Full-Year 2022 Financial Results and Operational Highlights

    BURLINGTON, Mass. and JERUSALEM, March 15, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported fourth quarter and full-year 2022 financial results and provided an operational update. Recent Financial and Operational Highlights For the three months ended December 31, 2022, revenues were $6.0 million, a 29% decrease as compared to the prior year period.As of December

  • GlobeNewswire

    BrainsWay Named to Fast Company’s 2023 List of the World’s Most Innovative Companies

    Joins the Ranks of OpenAI, Disney, and Tiffany & Co.BURLINGTON, Mass. and JERUSALEM, March 02, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023. This year’s list highlights the businesses at the forefront of their respective in